Literature DB >> 6457871

Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice.

H D Engers, J A Louis, R H Zubler, B Hirt.   

Abstract

A purified preparation of MVM(i), a murine parvovirus closely related to minute virus of mice (MVM), was found to inhibit various functions mediated by murine T cells in vitro. Addition of MVM(i) virus to secondary allogeneic mixed leukocyte cultures resulted in the inhibition of both lymphocyte proliferation (3H-thymidine incorporation) and the generation of cytolytic T lymphocyte activity but not interferon production. MVM(i) virus also inhibited the growth and cytolytic activity of several cloned, long-term Lyt-2+ cytolytic T cell lines. Furthermore, the antigen-induced proliferative responses of parasite- (Leishmania) specific Lyt-1+ T cells in vitro was abrogated by the addition of MVM(i) virus to the culture. Finally, the suppression of an in vitro antibody response to SRBC by MVM(i) virus was the result of the inhibition of T helper cells required for the B cell response. These suppressive effects were specific for MVM(i); parallel studies in which the prototype MVM parvovirus was used showed no significant inhibition in the various systems tested.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457871

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.

Authors:  Susanne I Lang; Stephanie Boelz; Alexandra Y Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Jan J Cornelis
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Transcriptional analysis of minute virus of mice P4 promoter mutants.

Authors:  J K Ahn; B J Gavin; G Kumar; D C Ward
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  Nucleoprotein complexes of minute virus of mice have a distinct structure different from that of chromatin.

Authors:  C Doerig; G McMaster; J Sogo; H Bruggmann; P Beard
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i).

Authors:  J C Segovia; J A Bueren; J M Almendral
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Immune responses to the major capsid protein during parvovirus infection of rats.

Authors:  Lisa J Ball-Goodrich; Frank X Paturzo; Elizabeth A Johnson; Krista Steger; Robert O Jacoby
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant VP2 proteins.

Authors:  Robert S Livingston; David G Besselsen; Earl K Steffen; Cynthia L Besch-Williford; Craig L Franklin; Lela K Riley
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice.

Authors:  J C Segovia; J M Gallego; J A Bueren; J M Almendral
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells.

Authors:  J R Schlehofer; M Rentrop; D N Männel
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

10.  Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.

Authors:  Lisa M Mattei; Susan F Cotmore; Peter Tattersall; Akiko Iwasaki
Journal:  Virology       Date:  2013-05-12       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.